Home Latest Filings Latest Buys Latest Sells Institutions Derivatives Hot Buys Data Screener Email Alerts Insider Charts
NMIH - As of  05/16/24, 08:32:29 AM:   18 Insider Transactions.

Sector: Financial    Industry: Surety & Title Insurance
Prev Close:$5.71  Avg Vol(3m): 467,448  P/E: 0.00  EPS: -0.41

Email this page to a friend.    Insider Transactions for NMIH

Buy/Sell* Filed Date Subject Symbol Acquirer Pct Owned Details
B 2020-09-10 12:01:01.0 KalVista Pharmaceuticals KALV FMR LLC 10.034% view
S 2020-02-14 16:07:48.0 KalVista Pharmaceuticals KALV Venrock Healthcare Capital Partners II 5.7% view
B 2020-02-13 12:45:19.0 KalVista Pharmaceuticals KALV EVENTIDE ASSET MANAGEMENT 9.4% view
S 2019-04-18 18:35:52.0 KalVista Pharmaceuticals KALV RA CAPITAL MANAGEMENT 5.6% view
S 2019-04-03 15:27:02.0 KalVista Pharmaceuticals KALV SVLSF IV 11.5% view
B 2018-09-12 16:32:32.0 KalVista Pharmaceuticals KALV Vivo Ventures VI 12.3% view
B 2018-08-09 16:33:24.0 KalVista Pharmaceuticals KALV Venrock Healthcare Capital Partners II 6.6% view
B 2017-11-13 16:31:49.0 KalVista Pharmaceuticals KALV Longwood Fund II 8.7% view
S 2017-10-16 10:59:02.0 KalVista Pharmaceuticals KALV Novo Holdings A 0.0% view
B 2017-09-22 17:21:56.0 KalVista Pharmaceuticals CBYL SVLSF IV 26.6% view
B 2017-02-14 16:26:39.0 KalVista Pharmaceuticals CBYL Vivo Ventures VI 16.0% view
B 2017-02-07 14:51:49.0 KalVista Pharmaceuticals CBYL SVLSF IV 26.6% view
S 2016-11-30 16:24:02.0 Carbylan Therapeutics CBYL PRICE T ROWE ASSOCIATES INC 1.7% view
S 2016-04-11 09:57:07.0 Carbylan Therapeutics CBYL FMR LLC 10.2% view
B 2016-02-12 09:01:23.0 Carbylan Therapeutics CBYL FMR LLC 5.5% view
B 2015-05-11 14:17:50.0 Carbylan Therapeutics CBYL PRICE T ROWE ASSOCIATES INC 12.622% view
B 2015-04-24 16:17:31.0 Carbylan Therapeutics CBYL Vivo Ventures VI 16.0% view
B 2015-04-21 06:16:00.0 Carbylan Therapeutics n/a Broadfin Capital 5.2% view
* Institutions do not report transaction buy/sell types directly. To help members better understand the transactions, this column is filled by InsiderCow's best-effort interpretations.